Neurochemistry International

Papers
(The H4-Index of Neurochemistry International is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Polarization to M1-type microglia in the hippocampus is involved in depression-like behavior in a mouse model of olfactory dysfunction97
A topographic approach to the markers of macrophage/microglia and other cell types in high grade glioma74
SPP1 expression after spinal cord compression injury and its effects on glial cell activation73
Epitranscriptomic dysregulation in neurodegenerative diseases and its implications for disease pathology and mechanisms72
Opioids induce constipation by prompting alpha-Synuclein hyperphosphorylation in the colonic myenteric plexus71
IL-17A enhances the inflammatory response of glaucoma through Act1/TRAF6/NF-κB pathway56
GABAA receptor participation in anxiolytic and anticonvulsant effects of (E)-3-(furan-2-yl)-1-(2hydroxy-3,4,6-trimethoxyphenyl)prop-2-en-1-one in adult zebrafish56
Combined administration of cocaine and alcohol alters the expression of brain peptide/protein profiles in rats: a MALDI imaging mass spectrometry approach55
Boron: An intriguing factor in retarding Alzheimer's progression53
Reduction in presynaptic glutamate release and the prevention of glutamate excitotoxicity by lupeol in rats49
p53 lysine-lactylated modification contributes to lipopolysaccharide-induced proinflammatory activation in BV2 cell under hypoxic conditions48
Beyond plaques and tangles: The role of immune cell dysfunction in Alzheimer's disease44
Repetitive transcranial magnetic stimulation as a universal modulator of synaptic plasticity: Bridging the gap between functional and structural plasticity44
Essential oils by name and by nature: a review of their antioxidant and neuroprotective potential in Parkinson's disease43
Transgenerational non-genomic transmission of acquired nervous system Phenotypes: Narrative review and epigenetic insights43
Circular RNA XRCC5 aggravates glioma progression by activating CLC3/SGK1 axis via recruiting IGF2BP243
The epigenetic mechanism of sleep disorders related cognitive impairment42
A2AR antagonists triggered the AMPK/m-TOR autophagic pathway to reverse the calcium-dependent cell damage in 6-OHDA induced model of PD40
Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds37
The neuroprotective effects of phosphoglycerate mutase 5 are mediated by decreasing oxidative stress in HT22 hippocampal cells and gerbil hippocampus37
Thiamet-G ameliorates Parkinson's disease-associated cognitive impairment via increasing O-GlcNAcylation of STING in the microglia36
Deferasirox exerts anti-epileptic effects by improving brain iron homeostasis via regulation of ITPRIP33
A multiscale atlas of Oprm1-expressing neurons in the central nervous system: Brain-wide distribution, circuit functions, and translational therapeutic implications33
M2a macrophages regulate fibrosis and affect the outcome after stroke via PU.1/mTOR pathway in fibroblasts33
Monoaminergic system involvement in the antidepressant-like and anxiolytic-like properties of novel β-dihydroagarofuran sesquiterpene alkaloid and triterpenes isolated from Gymnosporia heterophylla ae29
USP53 promotes NOTCH2-induced neuroinflammation in Alzheimer's disease.29
HIF-1, an important regulator in potential new therapeutic approaches to ischemic stroke29
Ras, RhoA, and vascular pharmacology in neurodevelopment and aging28
Editorial Board28
0.099467992782593